1 / 8

INFOBIOMED

INFOBIOMED. WP 6.1. NRacl: Continuously updated annotated chemical library. INFOBIOMED. WP 6.1. Mapping ligands to nuclear receptor pathways. INFOBIOMED. WP 6.1. Mapping ligands to nuclear receptor pathways. INFOBIOMED. WP 6.1. Paper production 2005-2007:. INFOBIOMED. WP 6.1-6.2.

tarmon
Download Presentation

INFOBIOMED

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. INFOBIOMED WP 6.1 NRacl: Continuously updated annotated chemical library

  2. INFOBIOMED WP 6.1 Mapping ligands to nuclear receptor pathways

  3. INFOBIOMED WP 6.1 Mapping ligands to nuclear receptor pathways

  4. INFOBIOMED WP 6.1 Paper production 2005-2007:

  5. INFOBIOMED WP 6.1-6.2 WOMBAT (ACL) DICTIONARIES EC.1.1.1.1 NR.1.A.1 TC.1.A.1.1.1 GR.A.1.1.1 IC.1.1.1.1 Druggability of the IFN pathway UEDIN GENES PROTEINS Small molecules

  6. INFOBIOMED WP 6.1-6.2 DICTIONARIES Druggability of the IFN pathway: gene-protein mapping GENES PROTEINS Gene Symbol Protein Name Target ID ABCA1 ATP-binding cassette, sub-family G (WHITE), member 1 TC.3.A.1.211.1 ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1 TC.3.A.1.204.3 ACSL1 Long-chain-fatty-acid-coA ligase 1 EC.6.2.1.3 ADSSL1 Adenylosuccinate synthetase isozyme 1 EC.6.3.4.4 AGTRAP Angiotensin II receptor-associated protein GR.A.2.1.2 AKR1B10 Aldo-keto reductase family 1 member B10 EC.1.1.1.- … … …

  7. INFOBIOMED WP 6.1-6.2 WOMBAT (ACL) Druggability of the IFN pathway: protein-ligand mapping EC.1.1.1.- EC.1.1.1.34 EC.1.11.1.7 EC.1.14.13.39 EC.1.14.99.1 EC.1.14.99.3 EC.1.14.99.5 EC.1.14.99.7 EC.1.15.1.1 EC.1.17.4.1 EC.1.2.1.3 EC.1.3.99.7 EC.1.4.3.13 EC.1.5.1.20 EC.2.1.1.45 EC.2.1.1.63 EC.2.3.1.48 EC.2.3.1.85 EC.2.4.1.149 EC.2.4.1.150 EC.2.4.2.12 EC.2.4.2.3 EC.2.5.1.18 EC.2.5.1.56 EC.2.7.1.- EC.2.7.1.123 EC.2.7.1.137 EC.2.7.1.21 EC.2.7.1.37 EC.2.7.1.40 EC.2.7.10.1 EC.2.7.11.1 EC.2.7.11.24 EC.2.7.11.25 r-EC.2.7.11.22 EC.2.7.4.4  EC.2.7.6.5 EC.2.7.7.- EC.2.7.7.7 EC.2.7.9.3 etc… PROTEINS Small molecules EC.n.n.n.n WOMBAT contains ligands annotated to EC.n.n.n.n none WOMBAT ligand annotated to r-EC.n.n.n.n Gene related to this target

  8. INFOBIOMED WP 6.1-6.2 Druggability of the IFN pathway: summary to date 136 Genes Identified  21.5 % IFN pathway druggable 636 Genes IFN pathway

More Related